Ad is loading...
ATBPF
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Apr 8 closing price
CDIO
Price
$0.55
Change
+$0.09 (+19.57%)
Updated
Dec 6, 04:59 PM (EDT)
Ad is loading...

ATBPF vs CDIO

Header iconATBPF vs CDIO Comparison
Open Charts ATBPF vs CDIOBanner chart's image
Antibe Therapeutics
Price$0.22
Change+$0.03 (+15.79%)
Volume$33.94K
CapitalizationN/A
Cardio Diagnostics Holdings
Price$0.55
Change+$0.09 (+19.57%)
Volume$23.6K
CapitalizationN/A
ATBPF vs CDIO Comparison Chart
Loading...
ATBPF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CDIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ATBPF vs. CDIO commentary
Dec 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATBPF is a Buy and CDIO is a Buy.

COMPARISON
Comparison
Dec 07, 2024
Stock price -- (ATBPF: $0.22 vs. CDIO: $0.46)
Brand notoriety: ATBPF and CDIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATBPF: 100% vs. CDIO: 1165%
Market capitalization -- ATBPF: $11.43M vs. CDIO: $18.78M
ATBPF [@Biotechnology] is valued at $11.43M. CDIO’s [@Biotechnology] market capitalization is $18.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATBPF’s FA Score shows that 0 FA rating(s) are green whileCDIO’s FA Score has 0 green FA rating(s).

  • ATBPF’s FA Score: 0 green, 5 red.
  • CDIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATBPF is a better buy in the long-term than CDIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATBPF’s TA Score shows that 1 TA indicator(s) are bullish while CDIO’s TA Score has 7 bullish TA indicator(s).

  • ATBPF’s TA Score: 1 bullish, 0 bearish.
  • CDIO’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, CDIO is a better buy in the short-term than ATBPF.

Price Growth

ATBPF (@Biotechnology) experienced а 0.00% price change this week, while CDIO (@Biotechnology) price change was +54.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.51%. For the same industry, the average monthly price growth was -1.06%, and the average quarterly price growth was +12.57%.

Reported Earning Dates

CDIO is expected to report earnings on Mar 31, 2023.

Industries' Descriptions

@Biotechnology (+0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDIO($18.8M) has a higher market cap than ATBPF($11.4M). ATBPF YTD gains are higher at: -68.387 vs. CDIO (-81.349).
ATBPFCDIOATBPF / CDIO
Capitalization11.4M18.8M61%
EBITDAN/A-7.89M-
Gain YTD-68.387-81.34984%
P/E RatioN/AN/A-
RevenueN/A35.7K-
Total CashN/A1.98M-
Total DebtN/A720K-
FUNDAMENTALS RATINGS
ATBPF: Fundamental Ratings
ATBPF
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATBPFCDIO
RSI
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
60%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
23%
View a ticker or compare two or three
Ad is loading...
ATBPF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CDIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFCMX17.610.05
+0.28%
American Century Focused Intl Gr R6
WDSCX21.79N/A
N/A
Allspring SMID Cap Growth Fund - Cl C
PMFRX11.62N/A
N/A
Pioneer Multi-Asset Income R
RWMHX65.70-0.20
-0.30%
American Funds Washington Mutual R5E
PSVKX20.53-0.19
-0.92%
PGIM Quant Solutions Small-Cap Val R4

ATBPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATBPF
1D Price
Change %
ATBPF100%
N/A
IRON - ATBPF
53%
Loosely correlated
-3.34%
KMSTF - ATBPF
52%
Loosely correlated
N/A
SRZN - ATBPF
47%
Loosely correlated
-2.91%
CDIO - ATBPF
25%
Poorly correlated
+56.05%
BIOR - ATBPF
23%
Poorly correlated
-9.09%
More

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with KRRO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
+56.05%
KRRO - CDIO
35%
Loosely correlated
+1.32%
ALEC - CDIO
34%
Loosely correlated
+0.46%
UBX - CDIO
31%
Poorly correlated
+6.25%
CPRX - CDIO
30%
Poorly correlated
-1.18%
RCUS - CDIO
28%
Poorly correlated
+0.06%
More